These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36894324)

  • 21. AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies.
    Yamada K; Shikida N; Shimbo K; Ito Y; Khedri Z; Matsuda Y; Mendelsohn BA
    Angew Chem Int Ed Engl; 2019 Apr; 58(17):5592-5597. PubMed ID: 30854738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates.
    Acchione M; Kwon H; Jochheim CM; Atkins WM
    MAbs; 2012; 4(3):362-72. PubMed ID: 22531451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxins.
    Spidel JL; Albone EF; Cheng X; Vaessen B; Jacob S; Milinichik AZ; Verdi A; Kline JB; Grasso L
    MAbs; 2017; 9(6):907-915. PubMed ID: 28541812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody Glycoengineering and Homogeneous Antibody-Drug Conjugate Preparation.
    Manabe S; Yamaguchi Y
    Chem Rec; 2021 Nov; 21(11):3005-3014. PubMed ID: 33886147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site.
    Kumar A; Mao S; Dimasi N; Gao C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.
    Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D
    MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Conjugation Site and Technique on the Stability and Pharmacokinetics of Antibody-Drug Conjugates.
    Kaempffe A; Dickgiesser S; Rasche N; Paoletti A; Bertotti E; De Salve I; Sirtori FR; Kellner R; Könning D; Hecht S; Anderl J; Kolmar H; Schröter C
    J Pharm Sci; 2021 Dec; 110(12):3776-3785. PubMed ID: 34363839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody and antibody fragments site-specific conjugation using new Q-tag substrate of bacterial transglutaminase.
    El Alaoui M; Sivado E; Jallas AC; Mebarki L; Dyson MR; Perrez F; Valsesia-Wittmann S; El Alaoui S
    Cell Death Discov; 2024 Feb; 10(1):79. PubMed ID: 38360912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Two Chemoenzymatic Glycan Remodeling Approaches to Generate Site-Specific Antibody-Drug Conjugates.
    Yang Q; Chen H; Ou C; Zheng Z; Zhang X; Liu Y; Zong G; Wang LX
    Antibodies (Basel); 2023 Nov; 12(4):. PubMed ID: 37987249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates.
    Farias SE; Strop P; Delaria K; Galindo Casas M; Dorywalska M; Shelton DL; Pons J; Rajpal A
    Bioconjug Chem; 2014 Feb; 25(2):240-50. PubMed ID: 24359082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2015 Jun; 87(11):5669-76. PubMed ID: 25938577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.
    Datta-Mannan A; Choi H; Stokell D; Tang J; Murphy A; Wrobleski A; Feng Y
    AAPS J; 2018 Sep; 20(6):103. PubMed ID: 30255287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies.
    Kotapati S; Passmore D; Yamazoe S; Sanku RKK; Cong Q; Poudel YB; Chowdari NS; Gangwar S; Rao C; Rangan VS; Cardarelli PM; Deshpande S; Strop P; Dollinger G; Rajpal A
    Anal Chem; 2020 Jan; 92(2):2065-2073. PubMed ID: 31860282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic conjugation using branched linkers for constructing homogeneous antibody-drug conjugates with high potency.
    Anami Y; Xiong W; Gui X; Deng M; Zhang CC; Zhang N; An Z; Tsuchikama K
    Org Biomol Chem; 2017 Jul; 15(26):5635-5642. PubMed ID: 28649690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
    Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
    J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-Specific Conjugation of Monomethyl Auristatin E to Anti-CD30 Antibodies Improves Their Pharmacokinetics and Therapeutic Index in Rodent Models.
    Lhospice F; Brégeon D; Belmant C; Dennler P; Chiotellis A; Fischer E; Gauthier L; Boëdec A; Rispaud H; Savard-Chambard S; Represa A; Schneider N; Paturel C; Sapet M; Delcambre C; Ingoure S; Viaud N; Bonnafous C; Schibli R; Romagné F
    Mol Pharm; 2015 Jun; 12(6):1863-71. PubMed ID: 25625323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State-of-the-Art Native Mass Spectrometry and Ion Mobility Methods to Monitor Homogeneous Site-Specific Antibody-Drug Conjugates Synthesis.
    Deslignière E; Ehkirch A; Duivelshof BL; Toftevall H; Sjögren J; Guillarme D; D'Atri V; Beck A; Hernandez-Alba O; Cianférani S
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34073805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current methods for the synthesis of homogeneous antibody-drug conjugates.
    Sochaj AM; Świderska KW; Otlewski J
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
    Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
    Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological Evaluation of Antibody-Drug Conjugates Produced by Tag-Free Lipoate Ligase A Modification.
    Yamazaki S; Ito K; Aoki T; Arashida N; Watanabe T; Fujii T; Matsuda Y
    Biochemistry; 2024 Mar; 63(5):644-650. PubMed ID: 38350078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.